262
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Approaches to the detection of ovarian cancer

Pages S49-S53 | Accepted 09 Mar 2016, Published online: 19 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Milan Terzic, Gulzhanat Aimagambetova, Melanie Norton, Luigi Della Corte, Alejandro Marín-Buck, Juan Francisco Lisón, Juan José Amer-Cuenca, Gabriella Zito, Simone Garzon, Salvatore Caruso, Agnese Maria Chiara Rapisarda & Antonio Cianci. (2021) Scoring systems for the evaluation of adnexal masses nature: current knowledge and clinical applications. Journal of Obstetrics and Gynaecology 41:3, pages 340-347.
Read now

Articles from other publishers (4)

Hui‐Jing Luo, Zhi‐Dong Hu, Ming Cui, Xiao‐Fang Zhang, Wen‐Yan Tian, Chao‐Qun Ma, Ya‐Nv Ren & Zuo‐Liang Dong. (2023) Diagnostic performance of CA125 , HE4 , ROMA, and CPH‐I in identifying primary ovarian cancer . Journal of Obstetrics and Gynaecology Research 49:3, pages 998-1006.
Crossref
Doan Tu Tran, Van Khoa Vo, Minh Tam Le, Linus Chuang & Vu Quoc Huy Nguyen. (2021) Copenhagen Index versus ROMA in preoperative ovarian malignancy risk stratification: Result from the first Vietnamese prospective cohort study. Gynecologic Oncology 162:1, pages 113-119.
Crossref
S. Bendifallah, G. Body, E. Daraï & L. Ouldamer. (2019) Pertinence des marqueurs tumoraux, scores (cliniques et biologiques) et algorithmes à visée diagnostique et pronostique devant une masse ovarienne suspecte d’un cancer épithélial. Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l’égide du CNGOF et labellisée par l’INCa. Gynécologie Obstétrique Fertilité & Sénologie  47:2, pages 134-154.
Crossref
Julie L. Hentze, Claus Høgdall, Susanne K. Kjær, Jan Blaakær & Estrid Høgdall. (2017) Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project. Contemporary Clinical Trials Communications 8, pages 167-174.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.